We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-12.52%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$6.47B
AUM Growth
-$1.7B
Cap. Flow
-$612M
Cap. Flow %
-9.46%
Top 10 Hldgs %
39.4%
Holding
758
New
244
Increased
84
Reduced
79
Closed
303

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$69.4M
2
MS icon
Morgan Stanley
MS
+$50.7M
3
C icon
Citigroup
C
+$50.1M
4
AMZN icon
Amazon
AMZN
+$49.8M
5
WBD icon
Warner Bros
WBD
+$42.6M

Top Sells

Rank Stock Value
1
IFF icon
International Flavors & Fragrances
IFF
+$284M
2
TMUS icon
T-Mobile US
TMUS
+$161M
3
QCOM icon
Qualcomm
QCOM
+$151M
4
MU icon
Micron Technology
MU
+$149M
5
BABA icon
Alibaba
BABA
+$144M

Sector Composition

Rank Sector Weight
1 Healthcare 11.55%
2 Communication Services 6.92%
3 Consumer Discretionary 5.57%
4 Utilities 3.44%
5 Financials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVGI icon
401
Commercial Vehicle Group
CVGI
$134M
$78K ﹤0.01%
+13,318
New +$90.7K
VSTM icon
402
Verastem
VSTM
$615M
$74K ﹤0.01%
+5,328
New +$84.9K
MRNS
403
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$74K ﹤0.01%
+15,377
New +$93.5K
APYX icon
404
Apyx Medical
APYX
$146M
$70K ﹤0.01%
+11,981
New +$61.5K
RYTM icon
405
Rhythm Pharmaceuticals
RYTM
$7.95B
$68K ﹤0.01%
+16,322
New +$89.3K
HBIO icon
406
Harvard Bioscience
HBIO
$28.8M
$66K ﹤0.01%
+1,830
New +$82.6K
ARAY icon
407
Accuray
ARAY
$34.9M
$65K ﹤0.01%
+33,223
New +$82.9K
LBPH
408
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$65K ﹤0.01%
20,918
– –
GTHX
409
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$63K ﹤0.01%
+12,656
New +$70.1K
MMAT
410
DELISTED
Meta Materials Inc. Common Stock
MMAT
$62K ﹤0.01%
+601
New +$89.7K
KG
411
Kestrel Group
KG
$67.3M
$61K ﹤0.01%
+1,563
New +$69.9K
SCOR icon
412
Comscore
SCOR
$106M
$60K ﹤0.01%
+1,466
New +$61K
CVM icon
413
CEL-SCI Corp
CVM
$26M
$57K ﹤0.01%
+421
New +$43.9K
ORMP icon
414
Oramed Pharmaceuticals
ORMP
$175M
$57K ﹤0.01%
+12,393
New +$66.2K
MTRX icon
415
Matrix Service
MTRX
$326M
$56K ﹤0.01%
+11,134
New +$69.8K
CTXR icon
416
Citius Pharmaceuticals
CTXR
$18.6M
$55K ﹤0.01%
+2,412
New +$66.1K
YELL
417
DELISTED
Yellow Corporation Common Stock
YELL
$54K ﹤0.01%
+18,322
New +$74.3K
ORIC icon
418
Oric Pharmaceuticals
ORIC
$1.41B
$53K ﹤0.01%
+11,940
New +$47.6K
ITI
419
DELISTED
Iteris, Inc.
ITI
$53K ﹤0.01%
+18,395
New +$51.1K
SMSI icon
420
Smith Micro Software
SMSI
$16M
$51K ﹤0.01%
+518
New +$60.2K
TTSH
421
DELISTED
Tile Shop Holdings
TTSH
$50K ﹤0.01%
+16,360
New +$81.6K
DBTX
422
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$50K ﹤0.01%
11,990
– –
GAN
423
DELISTED
GAN Ltd
GAN
$49K ﹤0.01%
16,505
+1,007
+6% +$3.73K
OMER icon
424
Omeros
OMER
$986M
$49K ﹤0.01%
+17,897
New +$60.7K
ANNX icon
425
Annexon
ANNX
$883M
$48K ﹤0.01%
+12,629
New +$38.6K
15 16
17
18 19

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Laurion Capital Management held 758 positions worth $6.47B, down 21% from $8.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Laurion Capital Management withdrew a net $612M in Q2 2022, closing 303 positions and reducing 79 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $284M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Laurion Capital Management opened a new position in Morgan Stanley worth $47M.

  • Laurion Capital Management's largest Q2 2022 buy was Morgan Stanley: 618,580 shares worth $47M.
  • Laurion Capital Management added most to Lowe's Companies in Q2 2022, an estimated $69.4M increase.
  • Laurion Capital Management's biggest Q2 2022 reduction was T-Mobile US, cutting an estimated $161M.
  • Laurion Capital Management fully exited International Flavors & Fragrances in Q2 2022, selling an estimated $284M.
  • Laurion Capital Management's ten largest holdings make up 39% of its $6.47B portfolio in Q2 2022.
  • Laurion Capital Management opened 244 new positions and closed 303 in Q2 2022.
  • Laurion Capital Management's portfolio value fell 21% quarter-over-quarter to $6.47B.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.